Manufacturing

Pharmaceutical Outsourcing Manufacturing

Contract development and manufacturing companies, or CDMOs, provide a wide range of drug development, formulation and manufacturing services to companies that need outsourcing help to bring pharmaceutical products to market.

Full-service contract development and manufacturing companies can take on every aspect of drug development and manufacturing – many can develop a variety of dosage forms. Specialized CDMOs typically concentrate on one kind of dosage form.

Services offered by contract manufacturing organizations typically include, but are not limited to:

Formulation
Analytical Services
Blending
Coating
Tableting
Parenteral Product R&D and Manufacturing
Aseptic Filling
Unit Dose Semi-Solids

Transdermal Product Development and Manufacturing
Topicals
Converting
Packaging
Serialization
Shipment

Filter

Hide Filter

Pharmaceutical Manufacturing Program Launched
Tuesday, January 21, 2025
In response to the growing demand for skilled professionals in South Carolina's life sciences sector, The Ritedose Corporation has partnered with Newberry College to launch a new Pharmaceutical Manufacturing program, set to begin in the summer of ... read more
ReciBioPharm Receives Grant
Tuesday, January 21, 2025
ReciBioPharm, a division of Recipharm, has been awarded a three-year grant from the Bill & Melinda Gates Foundation (Gates Foundation). The funding will support the global deployment of xRNA Continuous Manufacturing technologies to LMICs. read more
dbDNA™ Manufacturing Facility Receives GMP License from MHRA
Tuesday, January 14, 2025
Touchlight has received a Manufacturer’s Authorization for Investigational Medicinal Products (MIA, IMP) license from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for the GMP (Good Manufacturing Practices) production of ... read more
Enhanc3D Genomics Launches 3D Multi-Omics Solutions
Tuesday, January 14, 2025
Based on the Company’s proprietary 3D genomics platform, integrated with extensive multi-omics analysis, the new 3D Multi-omic offerings provide partners with a powerful end-to-end solution to support and enhance decision-making through every stage ... read more
Alcami Names New CEO
Tuesday, January 14, 2025
Alcami Corporation announced the resignation of Bill Humphries. Alcami’s Board Chair and former Chief Executive Officer Patrick Walsh will serve as Interim CEO, ensuring the continuation of smooth operations and a strong client-centric approach from ... read more
Avéma Pharma Solutions Moved Under PLD Banner
Tuesday, January 14, 2025
With this move, PLD is consolidating its divisions with a unified identity that reflects the company’s commitment to developing and manufacturing high quality, liquid and solid dose OTC and Rx products to its customers. read more
ActiGraph Acquires Biofourmis Life Science Business
Tuesday, January 07, 2025
ActiGraph has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an AI-driven, digital trial platform tailored for the life science industry. The combined solution will create a market-leading, unified software ... read more
Platinum Press Expands Headquarters by 70,000 SF in $15M Investment
Tuesday, January 07, 2025
Platinum Press, Inc., a provider of printed packaging solutions for the pharmaceutical, natural health and consumer products industries specializing in labels, folding cartons, leaflets, foil lidding and flexible packaging, has completed a $15 ... read more
Gaelic Laboratories Expands Into the Middle East
Tuesday, January 07, 2025
Gaelic Laboratories has established a Commercial Arm in the UAE that enables the company to import, register, market and distribute medicines in the Middle East. With its newly opened Gaelic Drug Store LLC in Dubai, the company now has an ... read more
ProBioGen Expands Protein and Viral Manufacturing
Tuesday, January 07, 2025
ProBioGen announced the expansion of both protein and virus manufacturing at its Berlin headquarters. This includes the commissioning of an additional 1000L-scale GMP production line for proteins as well as the completion of the construction phase of... read more
I Peace Announces Manufacture of 100 lines of GMP iPS Cells Cumulatively
Thursday, January 02, 2025
GMP cell CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the number of GMP-grade iPS cells manufactured has reached 100 lines. read more
Innovent to Collaborate with Roche on Novel DLL3 Antibody Drug Conjugate
Thursday, January 02, 2025
Innovent Biologics, Inc. announced a collaboration and exclusive license agreement with Roche to advance the development of IBI3009, a novel DLL3-targeted antibody drug conjugate (ADC) candidate. IBI3009 has already obtained IND approvals in ... read more
Porton Pharma Solutions and Dragon Sail Pharmaceutical Partner on ADC Drug Development, Production, and Supply Chain
Thursday, January 02, 2025
Porton Pharma Solutions and Dragon Sail Pharmaceutical Co., Ltd. signed a strategic cooperation agreement in Guilin, southern of China. This collaboration aims to carry out in-depth cooperation in the research, development, production, and supply ... read more
Scinai Immunotherapeutics Establishes US-Based Scinai Bioservices Inc.
Thursday, December 19, 2024
Scinai Immunotherapeutics Ltd., a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, announced the establishment of a U.S.-... read more
Novo Holdings Completes Acquisition of Catalent
Thursday, December 19, 2024
Catalent, Inc. and Novo Holdings A/S announced that Novo Holdings has completed its previously announced acquisition of Catalent in an all-cash transaction with a total enterprise value of approximately $16.5 billion. read more